In fact, in CRC mice models Ucp2 deletion impacted glucose metabolism with the loss of UCP2’s cataplerotic function increasing C4 levels in the matrix, promoting the mitochondrial utilization of the glycolysis-derived pyruvate. The gene discussed is UCP2; the disease is colorectal carcinoma.